OGEN

Oragenics Inc.

0.82

USD

OGEN Earnings Reports

Positive Surprise Ratio

OGEN beat 13 of 20 last estimates.

65%

Next Report

Date of Next Report

Mar 12, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Oragenics Inc. earnings per share and revenue

On Nov 07, 2025, OGEN reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Oragenics Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Oragenics Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Oragenics Inc.'s Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Oragenics Inc. expected to report next?

The next earning report is scheduled for Mar 12, 2026.

What are the forecasts for Oragenics Inc.'s next earnings report?

Based on -- analysts, Oragenics Inc. is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.